Impact of NAFLD and Fibrosis on Adverse Cardiovascular Events in Patients With Hypertension
Yanqiu Huang(Shanghai Jiao Tong University), Tingya Wan(Shanghai Jiao Tong University), Liao Wang(Shanghai Ninth People's Hospital), Xu Jiang(Guiyang College of Traditional Chinese Medicine), Xiaoguang Li(Beijing University of Technology), Yang Yang(Chengdu University of Traditional Chinese Medicine), Juan Ji(Wuhan University of Technology), Hong Gao, Xiaoyu Wang(Shanghai Jiao Tong University), Yuemei Hong(Shanghai Jiao Tong University)
Cited by 15
Related Papers
The NF-κB Activation in Lymphotoxin β Receptor Signaling Depends on the Phosphorylation of p65 at Serine 536
|Journal of Biological Chemistry|2003|171
β-Blocker carvedilol protects cardiomyocytes against oxidative stress-induced apoptosis by up-regulating miR-133 expression
|Journal of Molecular and Cellular Cardiology|2014|113
Resolvin D1 reprograms energy metabolism to promote microglia to phagocytize neutrophils after ischemic stroke
|Cell Reports|2023|82
Inflammatory markers link triglyceride-glucose index and obesity indicators with adverse cardiovascular events in patients with hypertension: insights from three cohorts
|Cardiovascular Diabetology|2025|78
Circulating Exosomes Derived-miR-146a from Systemic Lupus Erythematosus Patients Regulates Senescence of Mesenchymal Stem Cells
|BioMed Research International|2019|70